Literature DB >> 16633737

Opposing action of estrogen receptors alpha and beta on tumor necrosis factor-alpha gene expression and caspase-8-mediated apoptotic effects in HA22T cells.

Erh-Jung Huang1, Cheng-Chung Wu, Shin-Da Lee, Juen-Hau Chen, Jer-Yuh Liu, Jiunn-Liang Ko, James A Lin, Min-Chi Lu, Li-Mien Chen, Chih-Yang Huang, Wei-Wen Kuo.   

Abstract

Hepatocellular carcinoma (HCC), the major manifestation of primary liver cancer, is one of the most frequent and malignant cancers worldwide, especially in Taiwan. Estrogen receptors (ERs) have been reported to play either a proliferation- or apoptosis-enhancing role in the differentiation of cancers, including HCC. In a previous experiment, we showed that transient overexpressed estrogen receptor-alpha induced early stage HCC cell line Hep 3B cell apoptosis by increasing the hTNF-alpha gene expression in a ligand-independent manner. To further clarify if the apoptotic effect occurs in poorly differentiated HCC cell line, HA22T, and elucidate the roles of ERs and TNF-alpha, DNA fragmentation and caspase activity were measured in late stage HCC cell line, HA22T, by measuring the expression of hER-alpha and hER-beta using a Tetracycline-inducible system (Tet-on). Increased DNA fragmentation and caspase-3 activity were found in hERbeta-overexpressed HA22T cells treated with estrogen (10(-8) M) but not in hERalpha-overexpressed HA22T cells. Using RT-PCR/PCR and western blotting in HA22T cells, overexpressed hER-beta was also found to increase the expression of hTNF-alpha mRNA and induce hTNF-alpha-dependent luciferase activity in a ligand-dependent manner. Additionally, LPS treatment and hER-beta overexpression both enhance caspase-8 activities, whereas neither hER-beta nor E2 treatment affected caspase-9 activities. In addition, the overexpressed hER-beta plus E2 enhanced DNA fragmentation and caspase-8 activities were only partially reduced by anti-hTNF-alpha (0.1 ng/ml), which was possibly due to the involvement of P53 and TGF-beta. Taken together, our data indicates that overexpressed hER-beta but not hER-alpha may induce caspase-8-mediated apoptosis by increasing the hTNF-alpha gene expression in a ligand-dependent manner in poorly differentiated HA22T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633737     DOI: 10.1007/s11010-005-9092-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

Review 1.  Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

Authors:  S Signoretti; M Loda
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer.

Authors:  T Ito; M Tachibana; S Yamamoto; J Nakashima; M Murai
Journal:  Eur Urol       Date:  2001-11       Impact factor: 20.096

Review 3.  Caspases: killer proteases.

Authors:  D W Nicholson; N A Thornberry
Journal:  Trends Biochem Sci       Date:  1997-08       Impact factor: 13.807

4.  Mechanisms of the induction of apoptosis in human hepatoma cells by tumour necrosis factor-alpha.

Authors:  J Li; R Zheng; J Li; Z Wang
Journal:  Cell Biol Int       Date:  2001       Impact factor: 3.612

5.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.

Authors:  G B Tremblay; A Tremblay; N G Copeland; D J Gilbert; N A Jenkins; F Labrie; V Giguère
Journal:  Mol Endocrinol       Date:  1997-03

6.  Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern.

Authors:  E Enmark; M Pelto-Huikko; K Grandien; S Lagercrantz; J Lagercrantz; G Fried; M Nordenskjöld; J A Gustafsson
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

7.  Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha.

Authors:  Woo Sung Moon; Kenneth Chang; Andrzej S Tarnawski
Journal:  Hum Pathol       Date:  2004-04       Impact factor: 3.466

8.  Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

Authors:  P A Konstantinopoulos; A Kominea; G Vandoros; G P Sykiotis; P Andricopoulos; I Varakis; G Sotiropoulou-Bonikou; A G Papavassiliou
Journal:  Eur J Cancer       Date:  2003-06       Impact factor: 9.162

9.  Estrogen receptor classification for hepatocellular carcinoma: comparison with clinical staging systems.

Authors:  Erica Villa; Alessandra Colantoni; Calogero Cammà; Antonella Grottola; Paola Buttafoco; Roberta Gelmini; Ilva Ferretti; Federico Manenti
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

10.  Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions.

Authors:  S C Lottich; W W Johnston; C A Szpak; E R Delong; A Thor; J Schlom
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

View more
  6 in total

1.  Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion.

Authors:  Hung-Ming Lam; C V Suresh Babu; Jiang Wang; Yong Yuan; Ying-Wai Lam; Shuk-Mei Ho; Yuet-Kin Leung
Journal:  Mol Cell Endocrinol       Date:  2012-02-19       Impact factor: 4.102

2.  Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.

Authors:  Stephen J McPherson; Shirin Hussain; Preetika Balanathan; Shelley L Hedwards; Birunthi Niranjan; Michael Grant; Upeksha P Chandrasiri; Roxanne Toivanen; Yuzhuo Wang; Renea A Taylor; Gail P Risbridger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

3.  Gene expression responses in male fathead minnows exposed to binary mixtures of an estrogen and antiestrogen.

Authors:  Natàlia Garcia-Reyero; Kevin J Kroll; Li Liu; Edward F Orlando; Karen H Watanabe; María S Sepúlveda; Daniel L Villeneuve; Edward J Perkins; Gerald T Ankley; Nancy D Denslow
Journal:  BMC Genomics       Date:  2009-07-13       Impact factor: 3.969

Review 4.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

5.  Estrogen and/or Estrogen Receptor α Inhibits BNIP3-Induced Apoptosis and Autophagy in H9c2 Cardiomyoblast Cells.

Authors:  Bih-Cheng Chen; Yi-Jiun Weng; Marthandam Asokan Shibu; Chien-Kuo Han; Yueh-Sheng Chen; Chia-Yao Shen; Yueh-Min Lin; Vijaya Padma Viswanadha; Hsin-Yueh Liang; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

Review 6.  The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.

Authors:  Yun Yang; Wen-Long Ye; Ruo-Nan Zhang; Xiao-Shun He; Jing-Ru Wang; Yu-Xuan Liu; Yi Wang; Xue-Mei Yang; Yu-Juan Zhang; Wen-Juan Gan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-22       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.